You are here:
Drugmakers
#

Drugmakers

Get Alerts

Articles

View all

India battles HIV/AIDS drug shortage as some firms halt supply

Sep 04, 2014

India battles HIV/AIDS drug shortage as some firms halt supply

India is facing a shortage of HIV/AIDS drugs provided under government's free medicine programme after drugmakers halted supplies due to delayed payment #NewsTracker #HIV #AIDS #HIV drugs #Indian drugmakers #NACO #shortage of medicine
Uh oh.. is Ranbaxy in more trouble?

Jan 13, 2014

Uh oh.. is Ranbaxy in more trouble?

The US Food and Drug Administration (FDA) has raised concerns about the manufacturing practices at a factory owned by Ranbaxy Laboratories, the drugmaker said on Monday, sending its shares down to nearly a one-month low. #United States #Ranbaxy #Daiichi Sankyo #US FDA #drugmaker #Toansa
Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

Nov 28, 2013

Largest PE investment in Indian pharma: KKR injects $200 mn into Gland Pharma

KKR'S latest investment in India underscores the positive outlook for generic drugmakers, despite some concerns about manufacturing quality after the recent crackdown by overseas regulators including the US Food and Drug Administration. #DealStream #Private equity #KKR #Pharma #drugmaker #Gland Pharma
US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Aug 12, 2013

US to hike fees for generic drugmakers from Oct; Indian firms to be hit

Many Indian drugmakers will soon have to bear higher costs for sale of products in American markets, as the US health regulator FDA is hiking the fees for generic drugmakers by up to 48 percent from October. #United States #NewsTracker #US FDA #drugmaker #Indian drugmakers
Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Jun 05, 2013

Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Ranbaxy may be facing a potential ban on its generic drugs in United States but however Ranbaxy is not the only company that has faced such a crisis. #WhyNow #Ranbaxy Laboratories #US FDA #generic drugmakers
Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Oct 01, 2014

States Try Secrecy to Protect Lethal Injection Drugmakers

Ohio's attorney general proposed shielding the identity of companies who provide drugs for execution, following the lead of other state... #Ohio #Ohio
Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Sep 30, 2014

Big Pharma's Money Ties To Doctors Revealed. Kind Of

The Obama administration unveiled a website Tuesday that will shed some much-needed light on Big Pharma's relationship with doctors. Just not quite today. Called Open Payments , it's a tool authorized by the Affordable Care Act that offers details on... #Barack Obama #Centers for Medicare and Medicaid Services
Ranbaxy $500 mn fine: Why single out India and Ranbaxy?

Sep 25, 2014

Fin24.com | Big task awaits GSK's new chair

The key task of GlaxoSmithKline's new chairperson Philip Hampton will be to help steer the drugmaker back to sustainable growth... #Barack Obama #Centers for Medicare and Medicaid Services